跳至主要内容
临床试验/NL-OMON53463
NL-OMON53463招募中不适用

Primary percutaneous stenting above the ampulla versus endoscopic drainage for unresectable malignant hilar biliary obstruction. - TESLA RCT

Erasmus MC, Universitair Medisch Centrum Rotterdam0 个研究点目标入组 148 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
招募中
入组人数
148

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
16 至 99(—)

入选标准

  • Written informed consent must be given according to ICH/GCP and
  • national/local regulations.
  • MHBO on imaging with histopathological confirmation or high clinical
  • Ineligible for surgical resection.
  • Hyperbilirubinemia (a combination of a total bilirubin level >50 mmol/l.

排除标准

  • Fluctuation or spontaneous decrease of a total bilirubin level before start
  • of any treatment suggesting a potential non-malignant diagnosis.
  • Patients who underwent previous biliary drainage procedures endoscopically or
  • percutaneously. Patients who underwent an attempted but failed ERCP are
  • eligible only when no papillotomy or cannulation was performed.
  • Clinical signs of cholangitis. Cholangitis is defined as the presence of both
  • fever (i.e. body temperature >38.5°C) and leucocytosis (i.e. >=10 *109/L)
  • without clinical or radiological evidence of acute cholecystitis (22).
  • Uncorrectable coagulation disorder.
  • Uncorrectable contrast allergy.

研究者

相似试验